๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Matt Miksic

Stock Analyst at Barclays

(3.84)
# 1,950
Out of 5,189 analysts
827
Total ratings
53.6%
Success rate
3%
Average return

Stocks Rated by Matt Miksic

Abbott Laboratories
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $143 → $120
Current: $103.00
Upside: +16.50%
Anteris Technologies Global
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $18 → $10
Current: $4.99
Upside: +100.40%
Baxter International
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $27 → $20
Current: $25.39
Upside: -21.23%
Becton, Dickinson and Company
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $204 → $165
Current: $212.78
Upside: -22.46%
Bausch + Lomb
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $20 → $24
Current: $19.38
Upside: +23.84%
Boston Scientific
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $89 → $48
Current: $41.98
Upside: +14.34%
DexCom
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $64 → $115
Current: $79.32
Upside: +44.98%
Edwards Lifesciences
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $110
Current: $101.85
Upside: +8.00%
GE HealthCare Technologies
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $78 → $85
Current: $80.64
Upside: +5.41%
Humacyte
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $1.5 → $0.5
Current: $0.4454
Upside: +12.26%
Initiated Coverage: Buy
Price Target: $651 → $485
Current: $399.05
Upside: +21.54%
Initiated Coverage: Buy
Price Target: $76 → $105
Current: $90.73
Upside: +15.73%
Initiated Coverage: Hold
Price Target: $198 → $150
Current: $133.17
Upside: +12.64%
Initiated Coverage: Hold
Price Target: $31 → $10
Current: $8.02
Upside: +24.69%
Initiated Coverage: Buy
Price Target: $394 → $375
Current: $310.00
Upside: +20.97%
Initiated Coverage: Hold
Price Target: $55 → $18
Current: $17.46
Upside: +3.09%
Initiated Coverage: Hold
Price Target: $94 → $100
Current: $101.10
Upside: -1.09%
Initiated Coverage: Hold
Price Target: $103 → $60
Current: $58.88
Upside: +1.90%
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $99.94
Upside: -4.94%
Initiated Coverage: Hold
Price Target: $26 → $22
Current: $16.01
Upside: +37.41%
Reiterated: Hold
Price Target: $255
Current: $270.47
Upside: -5.72%
Rated: Buy
Price Target: $12 → $13
Current: $6.58
Upside: +97.57%
Reiterated: Buy
Price Target: $123
Current: $66.89
Upside: +83.88%
Reiterated: Buy
Price Target: $21 → $19
Current: $12.42
Upside: +52.98%
Reiterated: Buy
Price Target: $27 → $24
Current: $6.68
Upside: +259.28%
Reiterated: Hold
Price Target: CHFย 75.93 → CHFย 65.81
Current: CHFย 62.28
Upside: +5.66%
Reiterated: Buy
Price Target: $25
Current: $0.7716
Upside: n/a
Reiterated: Buy
Price Target: $722 → $418
Current: $155.17
Upside: n/a
Reiterated: Buy
Price Target: $16 → $13
Current: $0.001
Upside: n/a
Reiterated: Buy
Price Target: $31 → $28
Current: $15.91
Upside: n/a
Reiterated: Buy
Price Target: $74 → $67
Current: $8.29
Upside: n/a
Reiterated: Buy
Price Target: $100
Current: $83.52
Upside: n/a
Reiterated: Buy
Price Target: $79 → $87
Current: $13.25
Upside: n/a
Initiated Coverage: Buy
Price Target: $55
Current: $22.91
Upside: n/a
Initiated Coverage: Sell
Price Target: $9
Current: $3.05
Upside: n/a
Initiated Coverage: Buy
Price Target: $21
Current: $1.20
Upside: n/a
Reiterated: Hold
Price Target: $37
Current: $29.83
Upside: n/a
Downgraded: Hold
Price Target: $30
Current: $6.08
Upside: n/a
Rated: Hold
Price Target: $33 → $36
Current: $46.56
Upside: n/a
Reiterated: Hold
Price Target: $43
Current: $6.07
Upside: n/a